Enerpac (EPAC) Reports Q1 Earnings and Revenues Below Expectations
Earnings Performance: Enerpac (EPAC) reported quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37, and showing a decline from $0.40 per share a year ago. The company has surpassed consensus EPS estimates only once in the last four quarters.
Revenue Results: The company posted revenues of $144.21 million for the quarter, falling short of the Zacks Consensus Estimate by 2.43% and down from $145.2 million year-over-year. Enerpac has exceeded revenue estimates twice in the past four quarters.
Stock Outlook: Enerpac shares have decreased by 4.1% since the start of the year, contrasting with the S&P 500's 15.6% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Manufacturing - Tools & Related Products industry ranks in the top 7% of Zacks industries, suggesting a favorable outlook. Investors are encouraged to monitor earnings estimate revisions, which can significantly influence stock performance.
Trade with 70% Backtested Accuracy
Analyst Views on EPAC
About EPAC
About the author

Earnings Decline: Enerpac Tool Group Corp. reported a decrease in earnings for the first quarter, with net earnings of $19.13 million ($0.36 per share) compared to $21.72 million ($0.40 per share) in the same period last year.
Adjusted Earnings: Excluding certain items, the adjusted earnings for the quarter were $19.20 million, maintaining the same earnings per share of $0.36.
Revenue Decrease: The company's revenue fell by 0.7%, totaling $144.21 million, down from $145.20 million in the previous year.
Financial Summary: Key financial figures include earnings of $19.13 million, EPS of $0.36, and revenue of $144.21 million, all reflecting a decline compared to the previous year.
- Sales Decline: Enerpac's Q1 net sales reached $144 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical achieved a notable 27% growth, indicating market demand variability.
- Profitability Fluctuations: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting a decrease in gross margin and slight operating expense deleveraging.
- Cash Flow Improvement: Operating cash flow increased to $16 million from $8.6 million in the previous year, demonstrating enhanced cash management and operational efficiency, which supports future investments and shareholder returns.
- Stable Outlook: Enerpac maintains its fiscal 2026 sales outlook, projecting net sales between $635 million and $655 million, reflecting the company's confidence in the market despite external economic uncertainties.
- Sales Decline: Enerpac's Q1 net sales reached $144.2 million, a 1% decrease year-over-year, primarily driven by a 3% organic sales decline in the IT&S segment, although Cortland Biomedical saw a significant 27% growth, indicating market demand disparities.
- Profitability Decline: The company reported net earnings of $19.1 million and diluted EPS of $0.36, down from $21.7 million and $0.40 in the prior year, reflecting lower gross margins and slight increases in operating expenses.
- Cash Flow Improvement: Operating cash flow improved to $16 million from $8.6 million in the previous year, indicating better cash management that supports future investments and shareholder returns.
- Shareholder Return Program: In Q1, the company repurchased approximately 377,000 shares for about $14.9 million, demonstrating a commitment to shareholder value while laying the groundwork for future returns.
Earnings Performance: Enerpac (EPAC) reported quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37, and showing a decline from $0.40 per share a year ago. The company has surpassed consensus EPS estimates only once in the last four quarters.
Revenue Results: The company posted revenues of $144.21 million for the quarter, falling short of the Zacks Consensus Estimate by 2.43% and down from $145.2 million year-over-year. Enerpac has exceeded revenue estimates twice in the past four quarters.
Stock Outlook: Enerpac shares have decreased by 4.1% since the start of the year, contrasting with the S&P 500's 15.6% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Manufacturing - Tools & Related Products industry ranks in the top 7% of Zacks industries, suggesting a favorable outlook. Investors are encouraged to monitor earnings estimate revisions, which can significantly influence stock performance.

Micron Technology, Inc. Earnings: Micron is expected to report earnings of $3.67 per share for the quarter ending November 30, 2025, reflecting a 126.54% increase year-over-year, with a strong track record of beating expectations.
Enerpac Tool Group Corp. Earnings: Enerpac's forecasted earnings per share is $0.38, indicating a 5.00% decrease from the previous year, but it has a higher Price to Earnings ratio compared to its industry peers.
Worthington Steel, Inc. Earnings: Worthington is projected to report earnings of $0.48 per share, a significant 152.63% increase from last year, with a favorable Price to Earnings ratio compared to the industry average.
MillerKnoll, Inc. Earnings: MillerKnoll's expected earnings per share is $0.41, showing a 25.45% decrease year-over-year, but it has consistently met or exceeded analyst expectations in the past year.









